Description

MYCOFORTIC S 360 is a pharmaceutical formulation containing Mycophenolic Acid Delayed-Release Tablets USP 360 mg. It belongs to the class of medicines known as immunosuppressants and is primarily used to help prevent organ rejection in patients who have undergone kidney transplantation. Mycophenolic acid works by suppressing certain immune system activities responsible for attacking foreign tissues. After an organ transplant, the body's immune system may recognise the transplanted kidney as foreign and attempt to reject it. This medicine helps reduce that immune response and supports long-term transplant management. MYCOFORTIC S 360 is a delayed-release tablet designed to release its active ingredient after passing through the stomach. It should be used only under the supervision of a qualified transplant specialist. Uses Mycophenolic Acid Delayed-Release Tablets USP 360 mg are primarily prescribed for preventing kidney transplant rejection. Important medical uses include: Prevention of Kidney Transplant Rejection: Helps suppress immune activity that may damage or reject a transplanted kidney. Post-Transplant Immunosuppression: Supports long-term management following kidney transplantation. Combination Therapy: Used alongside other prescribed immunosuppressant medicines, commonly cyclosporine and corticosteroids. The treatment is intended for eligible adult kidney transplant recipients and certain paediatric kidney transplant patients, as determined by their specialist. Benefits MYCOFORTIC S 360 offers several important therapeutic benefits when prescribed appropriately: Helps Prevent Organ Rejection: Reduces immune system activity directed against the transplanted kidney. Targeted Immunosuppressive Action: Helps control the activity and multiplication of immune cells involved in rejection. Delayed-Release Formulation: Designed to release mycophenolic acid in the intestine. Supports Transplant Management: Helps maintain the prescribed immunosuppressive treatment plan. Convenient Tablet Strength: The 360 mg strength allows specialists to organise individualised dosing schedules. Dosage The dosage of MYCOFORTIC S 360 depends on the patient's medical condition, transplant history, response to treatment and other prescribed medicines. For adults receiving kidney transplants, the commonly recommended total dose of mycophenolic acid delayed-release tablets is 720 mg twice daily, equivalent to 1,440 mg per day. However, this is a reference regimen and must not replace an individual prescription. Take the tablet on an empty stomach as directed. Swallow it whole with water. Do not crush, break or chew the delayed-release tablet. Never change the dosage or discontinue treatment without consulting your transplant specialist. Side Effects Some possible side effects associated with mycophenolic acid include: Nausea and vomiting Diarrhoea and constipation Abdominal discomfort Anaemia Reduced white blood cell count Headache Urinary tract infections Increased susceptibility to infections Contact your doctor if side effects persist or become severe. Fever, unusual bleeding, severe abdominal pain or signs of serious infection require prompt medical attention. Precautions and Warnings MYCOFORTIC S 360 requires careful medical supervision because it suppresses the immune system. Pregnancy: Mycophenolic acid can cause pregnancy loss and serious birth defects. Pregnancy prevention and planning must be discussed with a specialist. Infections: Patients may have an increased risk of bacterial, viral and fungal infections. Blood Monitoring: Regular blood tests may be required to monitor blood cell counts and treatment safety. Liver and Kidney Health: Inform your doctor about existing medical conditions. Drug Interactions: Inform your healthcare professional about all medicines and supplements you take. Cancer Risk: Long-term immunosuppression may increase the risk of lymphoma and certain skin cancers. Allergies: Avoid this medicine if you have a known allergy to mycophenolic acid or its ingredients. Do not substitute mycophenolic acid delayed-release tablets with mycophenolate mofetil products without medical supervision. Conclusion MYCOFORTIC S 360 (Mycophenolic Acid Delayed-Release Tablets USP 360 mg) is an immunosuppressant medicine used to help prevent kidney transplant rejection. Its delayed-release formulation and immune-modulating action make it an important option in post-transplant treatment plans. For safe and effective use, patients should follow their specialist's instructions, attend regular medical check-ups and undergo recommended laboratory monitoring.